Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised on the sale of Bygglet to Cordel
Mandate

Vinge has advised on the sale of Bygglet to Cordel

December 21, 2018 M&A

Vinge has advised the sellers in connection with the sale of all shares in Bygglet Holding AB to Cordel Norden AS, one of Valedo Partner’s portfolio companies.

Bygglet provides project management software within the building and facilities management industry. 

Vinge’s team primarily consisted of responsible partner Anders Strid, Anna Backman (M&A), Victor Ericsson (tax), Camilla Andersson (corporate assistant) and Pernilla Warg (VDR).
 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026